Description

Laferon-FarmBiotek Lyophilisate for Solution for Injections 1 mln IU №10 Vial

Ingredients:

The active ingredient in Laferon-FarmBiotek lyophilisate is Interferon alpha-2b, which is a protein that plays a crucial role in the body’s immune response.

Dosage:

The recommended dosage of Laferon-FarmBiotek lyophilisate is determined by a healthcare professional based on the specific condition being treated. It is typically administered via injection into a muscle or under the skin.

Indications:

Laferon-FarmBiotek lyophilisate is indicated for the treatment of certain viral infections, such as hepatitis B and C, as well as certain types of cancer, such as melanoma and leukemia.

Contraindications:

Do not use Laferon-FarmBiotek lyophilisate if you are allergic to Interferon alpha-2b or any other ingredients in the product. It is important to discuss any existing medical conditions or medications with your healthcare provider before starting treatment.

Directions:

Follow the instructions provided by your healthcare provider carefully when using Laferon-FarmBiotek lyophilisate. It is important to store the product as directed and use it within the recommended timeframe.

Scientific Evidence:

Studies have shown that Interferon alpha-2b, the active ingredient in Laferon-FarmBiotek lyophilisate, has antiviral and antitumor effects. Research published in the Journal of Interferon & Cytokine Research has demonstrated the efficacy of Interferon alpha-2b in treating hepatitis C infections.

Additional Information:

Laferon-FarmBiotek lyophilisate is a potent medication that should only be used under the supervision of a healthcare professional. It is important to discuss any potential side effects or concerns with your doctor before starting treatment.

Furthermore, clinical trials have shown promising results regarding the use of Interferon alpha-2b in combination therapy for certain types of cancer. These trials have highlighted the potential of this medication in improving patient outcomes and survival rates.